NDC 0143-9577-01 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9577
- Requested NDC
- 0143-9577-01
- Package NDCs from labels
- 0143-9577-01, 0143-9577-10
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine - A-S Medication Solutions | A-S Medication Solutions | 2026-10-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Sportpharm LLC | Sportpharm LLC | 2026-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2025-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - A-S Medication Solutions | A-S Medication Solutions | 2020-01-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9577-01 | Lidocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 6 | |
| 0143-9577-10 | Lidocaine | 10 in 1 PACKAGE | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9577 | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250521_5523fdfe-69fd-49a5-b51f-73e2223d49a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9577-01 | ML - Milliliter | 0143-9577 | ea2c7279-63c3-4b87-91db-5d19991bdd0e | 1 | 2017-10-13 |
| 0143-9577-10 | ML - Milliliter | 0143-9577 | 77c02fb7-615e-4921-9e5e-76cb34cd3b79 | 1 | 2017-10-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidotral 5% Gel | LIDOCAINE HCL | Puretek Corporation | 1e183af7-73d7-ff32-e063-6294a90a305b | 2024-07-25 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 96117178-ebf0-1335-e053-2a95a90ac105 | 2024-07-24 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | f55bd888-5e01-474d-871b-24654c070178 | 2024-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 83994d0c-8484-4505-abb5-8a384ed12288 | 2024-07-22 | Warnings, Adverse reactions | 451W47IQ8X |
| CVS Health Sunburn Relief Cooling | LIDOCAINE HYDROCHLORIDE | CVS PHARMACY | 1d6402ea-4201-27f9-e063-6294a90a43f5 | 2024-07-16 | Warnings | V13007Z41A |
| sodium chloride | SODIUM CHLORIDE | Becton Dickinson and Company | 8df7dcf6-8714-6caf-e053-2995a90ab8cc | 2024-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Burn Relief | LIDOCAINE HCI 2.0% | Trifecta Pharmaceuticals USA, LLC. | e5e524cd-bb22-715f-e053-2995a90ab5d3 | 2024-07-12 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | NorthStar RxLLC | f065e6d2-b47e-433d-a1fb-f0449cd725f1 | 2024-07-05 | Warnings, Adverse reactions | V13007Z41A |
| Solarcaine Burn Pain Relief 4oz | SOLARCAINE BURN PAIN RELIEF 4OZ | WellSpring Pharmaceutical Corporation | 2c0389db-ceb2-422b-9575-bdb8fe649a1e | 2024-06-26 | Warnings | V13007Z41A |
| ABREVA Rapid Pain Relief | GLYCERIN, LIDOCAINE | Haleon US Holdings LLC | 65bd242f-4c6a-436c-8ec0-7b2e0d73ed9d | 2024-06-20 | Warnings | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 1b584ef0-3663-0d2a-e063-6394a90a1757 | 2024-06-20 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 45416533-17a1-4757-b24e-b33d1ee57471 | 2024-06-20 | Warnings, Adverse reactions | 1010671 V13007Z41A |
| Neurozyl | LIDOCAINE HCL 4.12 % | PureTek Corporation | 1aca46c8-ff06-da0e-e063-6394a90a475f | 2024-06-13 | Warnings, Adverse reactions | V13007Z41A |
| Derma Pain Plus | CROTON TIGLIUM, NATRUM MURIATICUM, PLANTAGO MAJOR, RHUS TOXICODENDRON, SARSAPARILLA (SMILAX REGELII) | Peaceful Mountain, Inc. | 6fa79c31-e48e-4c83-baa2-96cef22cfee1 | 2024-06-13 | Warnings | 451W47IQ8X |
| Cold Sore Rescue | BORAX, DULCAMARA, NATRUM MURIATICUM, RANUNCULUS BULBOSUS, SILICEA | Peaceful Mountain, Inc. | a7fe6ec7-a758-43cf-b46f-c327e0632fb8 | 2024-06-13 | Warnings | 451W47IQ8X |
| NATRUM MUR | NATRUM MUR | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | 1a22655a-68f3-4f13-e063-6294a90ae52c | 2024-06-05 | Warnings | 451W47IQ8X |
| Lidotral Five Percent | LIDOCAINE HYDROCHLORIDE | PureTek Corporation | 1a156ffe-1ec9-d2f9-e063-6394a90a3381 | 2024-06-04 | Warnings, Adverse reactions | V13007Z41A |
| FIRST AID BURN | LIDOCAINE HYDROCHLORIDE,BENZALKONIUM CHLORIDE | Epic Medical Supply Corp | bd1b1873-e900-45eb-96a0-28f782b5a7cd | 2024-06-04 | Warnings | V13007Z41A |
| Lidotral 3.88 Percent Plus Hydrocortisone 1 Percent Cream | LIDOCAINE HCL, HYDROCORTISONE ACETATE | PureTek Corporation | 1a01b416-2ca5-c7fa-e063-6394a90a341b | 2024-06-03 | Warnings, Adverse reactions | V13007Z41A |
| Mentox HP | AURUM METALLICUM, BARYTA CARBONICA, CALCAREA CARBONICA, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS | Energique, Inc. | ebb23637-4931-4563-ab30-99bea0276580 | 2024-05-28 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.